Cannabis use in sickle cell disease: A questionnaire study

British Journal of Haematology

Volumn 131, Issue 1, 2005, Pages 123-128

  Howard, Jo ^a   Anie, Kofi A ^a   Holdcroft, Anita ^b   Korn, Simon ^a   Davies, Sally C ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cannabinoids; Cannabis; Pain; Sickle cell disease

Indexed keywords

CANNABIS;

ADULT; ANALGESIA; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; ATTENTION DISTURBANCE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; LEISURE; MALE; MOOD; MOOD CHANGE; PAIN; PARANOIA; PRIORITY JOURNAL; QUESTIONNAIRE; SEDATION; SICKLE CELL ANEMIA; SMOKING; SOMNOLENCE; ACUTE DISEASE; CANNABACEAE; CANNABIS ADDICTION; METHODOLOGY; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT;

ACUTE DISEASE; ADULT; ANEMIA, SICKLE CELL; CANNABACEAE; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PAIN; PHYTOTHERAPY; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 27744600231     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05723.x     Document Type: Article

References (29)

1. Anie K.A. Steptoe A. ( 2003) Pain, mood and opioid medication use in sickle cell disease. The Hematology Journal, 4, 71 73.
2. Anie K.A. Steptoe A. Bevan D.H. ( 2002) Sickle cell disease: pain, coping, and quality of life in a study of adults in the UK. British Journal of Health Psychology, 7, 331 344.
3. Arseneault L. Cannon M. Witton J. Murray R.M. ( 2004) Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110 117.
4. Campbell F.A. Tramer M.R. Carroll D. Reynolds D.J. Moore R.A. McQuay H.J. ( 2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. British Medical Journal, 323, 13 16.
5. Clark A.J. Ware M.A. Yazer E. Murray T.J. Lynch M.E. ( 2004) Patterns of cannabis use among patients with multiple sclerosis. Neurology, 62, 2098 2100.
6. Claster S. Vichinsky E.P. ( 2003) Managing sickle cell disease. British Medical Journal, 327, 151 155.
7. Dampier C. Ely E. Brodecki D. O'Neal P. ( 2002) Home management of pain in sickle cell disease: a daily diary study in children and adolescents. Journal of Pediatric Hematology and Oncology, 24, 643 647.
8. Dansak D.A. ( 1997) Medical use of recreational drugs by AIDS patients. Journal of Addiction Diseases, 16, 25 30.
9. Elander J. Lusher J. Bevan D. Telfer P. ( 2003) Pain management and symptoms of substance dependence among patients with sickle cell disease. Social Science and Medicine, 57, 1683 1696.
10. Fuggle P. Shand P.A. Gill L.J. Davies S.C. ( 1996) Pain, quality of life and coping in sickle cell disease. Archives of Diseases in Childhood, 75, 199 203.
11. Holdcroft A. Smith M. Jacklin A. Hodgson H. Smith B. Newton M. Evans F. ( 1997) Oral cannabinoids in Familial Mediterranean Fever: a case report. Anaesthesia, 52, 483 488.
12. Macleod J. Oakes R. Copello A. Crome I. Egger M. Hickman M. Oppenkowski T. Stokes-Lampard H. Davey Smith G. ( 2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal general population studies. Lancet, 363, 1579 1588.
13. Malfait A.M. Gallily R. Sumariwalla P.F. Malik A.S. Andreakos E. Mechoulam R. Feldman M. ( 2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences of the United States of America, 97, 9561 9566.
14. Mateo I. Pinedo A. Gomex-Beldarrain M. Basterretxea J.M. Garcia-Monco J.C. ( 2005) Recurrent stroke associated with cannabis use. Journal of Neurology, Neurosurgery and Psychiatry, 76, 435 437.
15. Maxwell K. Streetly A. Bevan D. ( 1999) Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. British Medical Journal, 318, 1585 1590.
16. Noyes Jr., R. Brunk S.F. Avery D.A. Canter A.C. ( 1975a) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics, 18, 84 89.
17. Noyes Jr., R. Brunk S.F. Baram D.A. Canter A. ( 1975b) Analgesic effect of delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology, 15, 139 143.
18. Page S.A. Verhoef M.J. Stebbins R.A. Metz L.M. Levy J.C. ( 2003) Cannabis use as described by people with multiple sclerosis. Canadian Journal of Neurological Science, 30, 201 205.
19. Prestage G.S. Kippax M. Grulich A. ( 1996) Use of treatments and health enhancement behaviours among HIV positive men in a cohort of homosexually active men. XI International Conference on AIDS. Vancouver, BC, Canada.
20. Ramsay M. Baker P. Goulden C. Sharp C. Sondhi A. ( 2001) Drug misuse declared in 2000: results from the British Crime Survey. In : Home Office Research Study 224. Home Office Research, Development and Statistics Directorate, Home Office, London Wright J. for the Committee for Standards in Haematology ( 2003) Guidelines for the management of acute painful crisis in sickle cell disease. British Journal of Haematology, 120, 744 752.
21. Shapiro B.S. Benjamin L.J. Payne R. Heidrich G. ( 1997) Sickle cell-related pain: perceptions of medical practitioners. Journal of Pain and Symptom Management, 14, 168 174.
22. Sidney S. ( 2001) Marijuana use in HIV positive and AIDS patients: results of an anonymous mail survey. In: Cannabis Therapeutics in HIV/AIDS ( ed. by E. Russo pp. 35 41. The Howarth Press, Binghamton, NY, USA Bach F.W. ( 2004) Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. British Medical Journal, 329, 253.
23. Wade D.T. Robson P. House H. Makela P. Aram J. ( 2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve neurogenic symptoms. Clinical Rehabilitation, 17, 21 29.
24. Walker M.J. Hohmann A.G. Martin W.J. Strangman N.M. Huang S.M. Tsou K. ( 1999) The neurobiology of cannabinoid analgesia. Life Sciences, 65, 665 673.
25. Ware M.A. Doyle C.R. Woods R. Lynch M.E. Clark A.J. ( 2003) Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain, 102, 211 216.
26. Welch S. Eads M. ( 1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research, 848, 183 190.
27. Wesner B. ( 1996) The medical marijuana issue among PWAs: reports of therapeutic use and attitudes towards legal reform. Working Paper No 3, Working Paper Series. Drug Research Unit, Social Science Research Institute, University of Hawaii.
28. Woolridge E. Barton S. Samuel J. Osorio J. Dougherty A. Holdcroft A. ( 2005) Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29, 358 367.
29. Zajicek J. Fox P. Sanders H. Wright D. Vickery J. Nunn A. Thompson A. ( 2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. The Lancet, 362, 1517 1526.